GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BRAIN Biotech AG (XTER:BNN) » Definitions » EBIT per Share

BRAIN Biotech AG (XTER:BNN) EBIT per Share : €-0.28 (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is BRAIN Biotech AG EBIT per Share?

BRAIN Biotech AG's EBIT per Share for the three months ended in Mar. 2024 was €-0.06. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.28.

During the past 3 years, the average EBIT per Share Growth Rate was 15.90% per year. During the past 5 years, the average EBIT per Share Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for BRAIN Biotech AG's EBIT per Share or its related term are showing as below:

XTER:BNN' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -11.7   Med: 9.55   Max: 30.8
Current: 15.9

During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of BRAIN Biotech AG was 30.80% per year. The lowest was -11.70% per year. And the median was 9.55% per year.

XTER:BNN's 3-Year EBIT Growth Rate is ranked better than
69.53% of 1267 companies
in the Chemicals industry
Industry Median: 3.2 vs XTER:BNN: 15.90

BRAIN Biotech AG's EBIT for the three months ended in Mar. 2024 was €-1.38 Mil.

BRAIN Biotech AG EBIT per Share Historical Data

The historical data trend for BRAIN Biotech AG's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BRAIN Biotech AG EBIT per Share Chart

BRAIN Biotech AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EBIT per Share
Get a 7-Day Free Trial Premium Member Only -0.59 -0.50 -0.19 -0.26 -0.30

BRAIN Biotech AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.08 -0.03 -0.10 -0.06

BRAIN Biotech AG EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

BRAIN Biotech AG's EBIT per Share for the fiscal year that ended in Sep. 2023 is calculated as

EBIT per Share(A: Sep. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=-6.631/21.847
=-0.30

BRAIN Biotech AG's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

EBIT per Share(Q: Mar. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-1.379/21.847
=-0.06

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BRAIN Biotech AG  (XTER:BNN) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

BRAIN Biotech AG EBIT per Share Related Terms

Thank you for viewing the detailed overview of BRAIN Biotech AG's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

BRAIN Biotech AG (XTER:BNN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BRAIN Biotech AG (XTER:BNN) » Definitions » EBIT per Share
Comparable Companies
XTER:MDG1 XTER:HPHA XTER:T5O OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN XBRU:UCB
Traded in Other Exchanges
BNN:Germany BNN:Germany BNN:Germany
Address
Darmstadter Strasse 34-36, Zwingenberg, BW, DEU, 64673
Website
https://www.brain-biotech.com
BRAIN Biotech AG is a technology company in the field of industrial biotechnology. It serves the chemical and consumer goods industries. The company develops novel biological ingredients such as enzymes, biocatalysts, and bioactive natural compounds. The company's segments include, BioProducts, BioScience and BioIncubator. Majority of the revenue is generated from its BioProducts segment which comprises of the product business with enzymes and other proteins for specific segments of the food industry. Geographically, the company generates majority of the revenue from United States of America and also has presence in other markets such as, Germany, France, United Kingdom and Netherlands.
Executives
Dr. Michael Majerus Supervisory Board
Dr. Georg Kellinghusen Supervisory Board
Michael Schneiders Board of Directors
Adriaan Moelker Board of Directors
Lukas Linnig Board of Directors

BRAIN Biotech AG (XTER:BNN) Headlines

No Headlines